Sharda Cropchem
SHARDACROP NSE
Sharda Cropchem
CommoditiesNSE: SHARDACROP BSE: 538666 Fertilizers & Agrochemicals
Key Fundamentals
MicrocapPesticides & AgrochemicalsChemicalsMarket Cap
₹6,924 Cr
Volatility
Moderate
P/E Ratio
11.03
EBITDA
₹1,182 Cr
Return on Equity
21.71%
Debt to Equity
0
Book Value
₹347.65
EPS
₹16.38
52W High
₹1,297
52W Low
₹755.55
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
4- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 23.8% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 43.8%
Weaknesses
2- Company has a low return on equity of 13.2% over last 3 years.
- Company has high debtors of 166 days.
Growth Rate
Revenue Growth
23.53% higher than
3Y
Net Income Growth
124% higher than
3Y
Cash Flow Change
8.63% lower than
3Y
ROE
78.39% higher than
3Y
ROCE
81.86% lower than
3Y
EBITDA Margin (Avg.)
45.99% lower than
3Y
AI Analysis — Bull vs Bear
anthropic claude-opus-4.6 69d agoAI opinion · based on fundamentals
Risk medium
Sharda Cropchem Ltd trades at a market cap of ₹8,345 Cr with a PE of 12.1x and has delivered TTM profit growth of 128% while remaining virtually debt-free. However, the company carries high debtor days of 166 and a 3-year average ROE of only 13.6%, reflecting working capital intensity in its asset-light agrochemical distribution model.
Bull Case 8
- TTM profit growth of 128% signals a sharp earnings recovery, with 5-year compounded profit CAGR at 25%
- Company is almost debt-free, reducing financial risk and interest burden significantly
- PE of 12.1x is modest relative to 5-year profit CAGR of 25%, implying earnings are not yet fully priced in
- Healthy dividend payout of 43.8% demonstrates shareholder-friendly capital allocation with 0.66% current yield
- Last year ROE jumped to 24%, well above the 3-year average of 14%, indicating improving capital efficiency
- Compounded sales CAGR of 17% over 5 years and 16% over 10 years shows consistent top-line growth trajectory
- Stock CAGR of 20% over 5 years and 19% over 3 years reflects sustained wealth creation for long-term holders
- Asset-light model with global registrations across 80+ countries provides a wide distribution moat with low capex needs
Bear Case 7
- High debtor days of 166 indicate significant working capital blockage and potential collection risk
- 3-year average ROE of only 13.6% is below par for a debt-free company, suggesting sub-optimal capital utilization
- 1-year stock CAGR of -1% shows the market has not rewarded recent earnings growth, signaling possible skepticism about sustainability
- Revenue is largely dependent on agrochemical commodity cycles with TTM sales growth of 22% potentially reflecting cyclical tailwinds rather than structural gains
- PB ratio of 2.62x for a company with 3-year ROE of only 14% implies limited margin of safety on book value basis
- Dividend yield of just 0.66% despite 43.8% payout ratio means absolute income generation for investors remains low
- 10-year stock CAGR of only 9% lags the broader market returns, suggesting long-term compounding has been inconsistent
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
anthropic claude-opus-4.6 69d ago Neutral 1
- Record date for FY26 dividend Jul 02
Sharda Cropchem fixed August 7, 2026 as the record date for its final dividend for FY26. The AGM is scheduled for August 14, 2026.
TL;DR: Limited recent news flow for Sharda Cropchem. The company has announced routine corporate actions with a record date for its FY26 final dividend set for August 7. No material headwinds or positive catalysts are visible from current news, leaving the near-term outlook dependent on upcoming quarterly results and agrochemical demand trends.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 638 | 581 | 632 | 1,312 | 785 | 777 | 929 | 1,829 | 985 | 929 | 1,289 | 2,065 | 1,074 |
| Expenses | 697 | 560 | 563 | 1,057 | 708 | 687 | 815 | 1,525 | 770 | 796 | 1,048 | 1,578 | 888 |
| Operating Profit | -59 | 21 | 69 | 255 | 77 | 90 | 115 | 303 | 215 | 133 | 241 | 487 | 186 |
| OPM % | -9% | 3.6% | 11% | 19% | 10% | 12% | 12% | 17% | 22% | 14% | 19% | 24% | 17% |
| Other Income | 26 | 24 | 12 | -2 | 19 | 25 | 1 | 25 | 32 | 29 | 21 | 22 | 35 |
| Interest | 1 | 5 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 |
| Depreciation | 70 | 74 | 69 | 54 | 65 | 69 | 69 | 72 | 78 | 76 | 83 | 87 | 100 |
| PBT | -105 | -34 | 12 | 198 | 31 | 46 | 46 | 256 | 169 | 86 | 179 | 422 | 118 |
| Tax % | -15% | -18% | 62% | 28% | 11% | 7% | 32% | 20% | 16% | 13% | 19% | 24% | 26% |
| Net Profit | -89 | -28 | 5 | 143 | 27 | 42 | 31 | 204 | 143 | 74 | 145 | 319 | 88 |
| EPS in Rs | -9.82 | -3.06 | 0.51 | 15.9 | 3.02 | 4.7 | 3.45 | 22.56 | 15.83 | 8.24 | 16.09 | 35.32 | 9.76 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,061 | 1,222 | 1,399 | 1,707 | 1,998 | 2,003 | 2,396 | 3,580 | 4,045 | 3,163 | 4,320 | 5,268 | 5,357 |
| Expenses | 878 | 941 | 1,075 | 1,343 | 1,621 | 1,653 | 1,945 | 2,884 | 3,386 | 2,860 | 3,705 | 4,209 | 4,310 |
| Operating Profit | 183 | 281 | 324 | 364 | 376 | 350 | 450 | 696 | 659 | 303 | 615 | 1,059 | 1,047 |
| OPM % | 17% | 23% | 23% | 21% | 19% | 17% | 19% | 19% | 16% | 10% | 14% | 20% | 20% |
| Other Income | 25 | 23 | 14 | 9 | -22 | -12 | 46 | 29 | 40 | 60 | 60 | 142 | 108 |
| Interest | 9 | 8 | 9 | 15 | 20 | 16 | 16 | 15 | 20 | 24 | 21 | 21 | 3 |
| Depreciation | 23 | 35 | 56 | 70 | 99 | 137 | 170 | 245 | 248 | 267 | 275 | 325 | 347 |
| PBT | 175 | 261 | 272 | 287 | 235 | 185 | 309 | 464 | 431 | 72 | 378 | 856 | 805 |
| Tax % | 30% | 33% | 30% | 34% | 25% | 11% | 26% | 25% | 21% | 56% | 20% | 20% | — |
| Net Profit | 123 | 175 | 190 | 191 | 176 | 165 | 229 | 349 | 342 | 32 | 304 | 681 | 626 |
| EPS in Rs | 13.63 | 19.41 | 21.11 | 21.14 | 19.55 | 18.25 | 25.4 | 38.71 | 37.9 | 3.53 | 33.74 | 75.47 | 69.41 |
| Div. Payout % | 18% | 21% | 19% | 19% | 20% | 22% | 20% | 16% | 16% | 85% | 27% | 20% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 |
| Reserves | 564 | 715 | 870 | 1,045 | 1,194 | 1,313 | 1,524 | 1,822 | 2,142 | 2,147 | 2,410 | 3,046 |
| Borrowings | 38 | 2 | 0 | 170 | 0 | 0 | 81 | 47 | 3 | 18 | 8 | 0 |
| Other Liabilities | 354 | 522 | 686 | 914 | 914 | 940 | 1,163 | 1,779 | 2,108 | 1,773 | 2,205 | 2,620 |
| Total Liabilities | 1,047 | 1,329 | 1,646 | 2,219 | 2,198 | 2,343 | 2,858 | 3,738 | 4,343 | 4,028 | 4,713 | 5,757 |
| Fixed Assets | 88 | 130 | 210 | 226 | 372 | 416 | 544 | 592 | 668 | 708 | 750 | 989 |
| CWIP | 149 | 210 | 232 | 360 | 220 | 161 | 131 | 212 | 204 | 283 | 291 | 247 |
| Investments | 95 | 90 | 61 | 22 | 212 | 116 | 83 | 134 | 32 | 159 | 294 | 361 |
| Other Assets | 715 | 899 | 1,143 | 1,611 | 1,394 | 1,650 | 2,099 | 2,800 | 3,439 | 2,878 | 3,377 | 4,159 |
| Total Assets | 1,047 | 1,329 | 1,646 | 2,219 | 2,198 | 2,343 | 2,858 | 3,738 | 4,343 | 4,028 | 4,713 | 5,757 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 46 | 197 | 181 | 17 | 556 | 146 | 246 | 267 | 328 | 341 | 604 | 656 |
| Investing | -19 | -113 | -104 | -160 | -351 | -59 | -282 | -205 | -112 | -393 | -496 | -445 |
| Financing | -24 | -89 | -38 | 132 | -215 | -60 | 43 | -91 | -97 | -37 | -68 | -118 |
| Net Cash Flow | 3 | -6 | 40 | -11 | -11 | 27 | 8 | -29 | 120 | -89 | 40 | 93 |
| Free Cash Flow | -34 | 196 | 39 | -185 | 413 | -30 | 15 | 33 | 84 | 69 | 211 | 158 |
| CFO/OP | 58 | 95 | 73 | 27 | 169 | 60 | 68 | 49 | 60 | 129 | 103 | 68 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 156 | 185 | 175 | 191 | 148 | 180 | 177 | 157 | 165 | 173 | 165 | 166 |
| Inventory Days | 72 | 74 | 117 | 169 | 96 | 100 | 117 | 130 | 145 | 155 | 117 | 121 |
| Days Payable | 117 | 179 | 186 | 202 | 167 | 180 | 180 | 172 | 176 | 144 | 158 | 162 |
| Cash Conversion Cycle | 111 | 81 | 106 | 158 | 77 | 100 | 114 | 115 | 134 | 184 | 124 | 125 |
| Working Capital Days | 82 | 95 | 99 | 94 | 71 | 101 | 94 | 88 | 97 | 128 | 92 | 102 |
| ROCE % | 27% | 36% | 32% | 27% | 23% | 18% | 21% | 26% | 21% | 4% | 16% | 30% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Sharda Cropchem insights
64 extracted metrics + investor summaries across FY13–FY27.
Documents
1
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
6 May - Post-results conference call for 4Q and FY26 earnings on 14 May 2026 at 1:00 p.m. IST. 6 May - Post-results conference call for 4Q and FY26 earnings on 14 May 2026 at 1:00 p.m. IST.
2
Board Meeting Intimation for Intimation Of Board Meeting For Adoption Of Audited Standalone & Consolidated Financial Results For The Year Ended 31St March, 2026.
5 May - Board meeting on 13 May 2026 to approve FY26 audited results and consider final dividend. 5 May - Board meeting on 13 May 2026 to approve FY26 audited results and consider final dividend.
3
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
3 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026. 3 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026.
5
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
4 Mar - Investor conference group meeting on 10 March 2026, 4-5pm (virtual) by Arihant Capital. 4 Mar - Investor conference group meeting on 10 March 2026, 4-5pm (virtual) by Arihant Capital.
Frequently Asked Questions about Sharda Cropchem
What does Sharda Cropchem Ltd do?
Sharda Cropchem is principally engaged in export of agrochemicals (technical grade and formulations) and non-agro products such as conveyor belts, rubber belts/sheets, dyes and dye intermediates to various countries across the world.
Where is Sharda Cropchem Ltd (SHARDACROP) listed?
Sharda Cropchem Ltd trades as SHARDACROP on the NSE and under code 538666 on the BSE.
Which sector does Sharda Cropchem Ltd belong to?
Sharda Cropchem Ltd is classified under the Commodities sector, in the Fertilizers & Agrochemicals industry.
What is the market capitalisation of Sharda Cropchem Ltd?
Sharda Cropchem Ltd has a market capitalisation of ₹6,924 Cr, which places it in the Mid Cap band.
What is the PE ratio of Sharda Cropchem Ltd?
Sharda Cropchem Ltd trades at a PE ratio of 11.03, on earnings per share of ₹16.38, against a book value of ₹347.65 per share.
What is the 52-week high and low of Sharda Cropchem Ltd?
Over the last 52 weeks Sharda Cropchem Ltd has traded between ₹755.55 and ₹1,297.
Does Sharda Cropchem Ltd pay dividends?
Sharda Cropchem Ltd has a dividend yield of 1.92%.
What is the Return on Equity (ROE) of Sharda Cropchem Ltd?
Sharda Cropchem Ltd reported a return on equity of 21.71%. Its debt-to-equity ratio is 0.00.
Company Information
Sharda Cropchem is principally engaged in export of agrochemicals (technical grade and formulations) and non-agro products such as conveyor belts, rubber belts/sheets, dyes and dye intermediates to various countries across the world.
Website shardacropchem.com
CEO Mr. Ramprakash Vilasrai Bubna
Employees 500
Listed 2014-09-23
Face Value ₹ 10
Issued Size 9,02,20,495
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SHARDACROP.md for Sharda Cropchem Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.